Novel Roadside Handheld Devices Offer Convenience of Drug Detection
An alarming rate of deaths caused due to drink and drive scenarios are increasingly becoming a matter of concern for government authorities worldwide. Thus, innovations in the healthcare industry are generating incremental opportunities for companies in the roadside drug testing devices market. For instance, in December 2019, Abbott-a global leader in medical devices announced the launch of the SoToxa™ Mobile Test System, which is acquiring global recognition. Novel roadside drug testing devices are gaining importance to combat drug-impaired driving and ensure road safety.
Get the sample copy of report@ https://qyresearchmedical.com/sample/111714
Companies in the roadside drug testing devices market are increasing their production capabilities to develop handheld devices. This is evident since handheld modality segment is estimated for exponential growth during the forecast period and the global roadside drug testing devices market is expected to reach a value of ~US$ 924 Mn by the end of 2027. Stakeholders in law enforcement are using oral fluid swabs that are inserted in handheld analyzers to detect marijuana and other drugs within minutes.
Driving Simulators Help in Conducting Successful Clinical Trials
As suggested by the Swinburne University of Technology, drug users are apparently surpassing the number of alcohol consumers in Australia, resulting in high rates of fatal crashes. Hence, companies in the roadside drug testing devices market should tap opportunities in Australia to increase the uptake of detection devices. Likewise, companies in the market for roadside drug testing devices are collaborating with researchers to increase R&D in psychology and neurosciences to ascertain if drivers under the influence of cannabis are more likely to meet with an accident, as compared to alcohol consumers.
With the introduction of driving simulators, companies in the roadside drug testing devices market are able to conduct better analysis of cognitive behavior and psychomotor functioning of individuals through the help of clinical trials. Companies in the market for roadside drug testing devices are gaining important insights through research findings carried out as a result of collaborations between universities and medical institutes.
Breathalyzers with Nanotechnology Sensors a Gold Standard for Detection of THC
Breathalyzers are becoming increasingly mainstream in the detection of alcohol in the roadside drug testing devices market. However, there is a growing need for breathalyzers that are also capable of detecting marijuana. Hence, researchers in the market for roadside drug testing devices are increasing R&D to develop novel breathalyzers that detect THC. For instance, an interdisciplinary team at the University of Pittsburgh, developed a breathalyzer using nanotechnology sensors that detect THC. Thus, innovative breathalyzers are increasingly becoming the gold standard for THC detection and manufacturers should collaborate with researchers to innovate in devices. This trend has supported the exponential growth of THC among other substance types in the roadside drug testing devices market.
View full report@ https://qyresearchmedical.com/report/roadside-drug-testing-devices-market-substance-drugs-tetrahydrocannabinol-thc-cocaine-amphetamine-benzodiazepines-opioids-and-others-and-alcohol-sample-type-saliva-sweat-urine-and-others-and-modalit-019-2030/111714
Companies in the roadside drug testing devices market are increasing research in developing breathalyzers using carbon nanotubes and nanotechnology sensors to meet requirements of mass spectrometry. This trend is prominent in the U.S. since legalization of recreational marijuana has raised concerns about the enforcement of DUI (Driving Under the Influence) laws in the region.
Innovations in THC Breathalyzers Generate Incremental Opportunities for Manufacturers
Since THC drugs segment is anticipated for exponential growth in the market for roadside drug testing devices, manufacturers are introducing breakthrough innovations that are a novel addition to the cannabis detection sector. For instance, Cannabix Technologies- a supplier of drug detection tools has announced that its scientific team has come up with a proprietary method-Field asymmetric waveform ion mobility spectrometry (FAIMS) to detect THC. Such innovations have contributed toward the modest of the roadside drug testing devices market, which is expected to expand at a CAGR of ~4% during the forecast period. Hence, manufacturers are focusing on innovating breathalyzers using high-field ion mobility and mass spectrometry.
Companies in the roadside drug testing devices market are developing lightweight devices that are user-friendly and store numerous samples. They are increasing efforts to develop devices that are capable of detecting extremely low quantities of THC analytes. Thus, innovative breathalyzers are increasingly replacing conventional breath analyzing techniques.
The roadside drug testing devices market is projected for exponential growth in North America. Lack of efficient DUI laws in the U.S. are fueling the demand for drug testing devices. Manufacturers are increasing efforts to meet the demand for breath analyzers that can detect extremely low quantities of THC analytes.
Increased research spending has become the key focus point of companies in the market landscape. However, incidences of false positives from poppy seeds and tea in drug testing devices act as barriers for market growth. Hence, manufacturers should develop devices that can differentiate between drugs or alcohol and food items that are merely in the system of an individual.
Roadside Drug Testing Devices Market: Overview
The global roadside drug testing devices market for the historical period of 2017–2018 and the forecast period of 2019–2027, increase in the number of drug and alcohol abusers and adoption of rapid test devices for screening or identification of drug and alcohol are anticipated to drive the global roadside drug testing devices market during the forecast period
According to the report, the global roadside drug testing devices market was valued at US$ 0.65 Bn in 2018. It is projected to expand at a CAGR of ~4% from 2019 to 2027.
Technological Advancements in Roadside Drug Testing Devices to Propel Market: A Key Driver
Roadside drug testing devices have already been adopted by the police force, with the introduction of a large number of new breathalyzer devices
Recent advancements by providers of drug, alcohol, and disease-testing products offer police with a robust set of roadside testing tools for the detection of alcohol and drug classes such as amphetamine, benzodiazepines, cannabis (THC), cocaine, methamphetamine, and opiates
New tests, such as paper spray mass spectrometry, analyze molecules in a fingerprint. As the body metabolizes a drug, it excretes molecules, which can (apparently) be detected in fingerprints by using the mass spectrometry method. The method works even after the hands are washed. Hence, there is no ‘coming clean’ with a quick trip to the sink. Researchers report 99% of accuracy rate by using this method.
Purchase Complete Report Now@ https://qyresearchmedical.com/report/checkout/111714/2900
Increase in the burden of drug and alcohol abuse and technological advancements have resulted in the adoption of portable roadside drug testing devices. Thus, rise in the demand for portable or handheld roadside drug testing devices is expected to propel the global roadside drug testing devices market during the forecast period.
Large Target Population
Increase in the number of drug and alcohol abusers across the world is expected to provide significant opportunities to test providers and manufacturers of drug abuse test products in the near future. According to the United Nations Office of Drug and Crime, over 5% of the global population aged between 15 and 64 years uses illicit drugs. Moreover, nearly 32.4 million people worldwide use pharmaceutical opioids and opiates such as opium or heroin.
According to the Centers for Disease Control and Prevention (CDC), around 4.7% of people aged 16 years or above in the U.S. are reported to be driving under the influence of marijuana and 0.9% are reported to be driving under the influence of illicit drugs other than marijuana.
Rise in target population and increase in government initiatives to control road accidents and fatalities in various countries are likely to drive the global roadside drug testing devices market during the forecast period
Inaccurate Results to Hamper Roadside Drug Testing Devices Market
Concerns about the efficacy and efficiency of roadside drug testing devices have increased over the last few years. For instance, in a study, which included over 300 Norway-based drivers who were tested for impairment by using both the oral device as well as the blood sample, it was found that the ratio of false-positive results generated by the device to findings of the blood sample was 14.5% for cannabis and 87.1% for cocaine.
Inaccurate results (false-positive or false-negative results) associated with roadside drug testing devices are projected to restrain the global roadside drug testing devices market during the forecast period
Roadside Drug Testing Devices Market: Competition Landscape
This report profiles major players operating in the global roadside drug testing devices market based on various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments
The roadside drug testing devices market is moderately fragmented with the presence of a few large-scale players in the global market and some small-scale players in regional markets. The top four to five players hold a major share of the global roadside drug testing devices market.
Prominent players operating in the global roadside drug testing devices market are
- Drägerwerk AG & Co. KgaA
- Abbott Laboratories
- Oranoxis Inc.
- CareHealth America
- MAVAND Solutions GmbH
- Pacific Data Systems Pty Ltd
- Securetec, and UriTox, LLC
Key Questions Answered in Roadside Drug Testing Devices Market Report
- What is the scope of growth of companies in the global roadside drug testing devices market?
- What will be the Y-o-Y growth of the global roadside drug testing devices market between 2019 and 2027?
- What is the influence of changing trends in technologies on the global roadside drug testing devices market?
- Will North America continue to be the most profitable market for roadside drug testing devices providers?
- Which factors will hamper the growth of the global roadside drug testing devices market during the forecast period?
- Which are the leading companies in the global roadside drug testing devices market?
Roadside Drug Testing Devices Market – Segmentation
- Tetrahydrocannabinol (THC)
- North America
- Asia Pacific
- Latin America
- Middle East & Africa
TABLE OF CONTENT
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Roadside Drug Testing Devices Market
4. Market Overview
4.1.1. Pricing Analysis
4.1.2. Industry Evolution/ Developments
4.3. Market Dynamics
4.4. Global Roadside Drug Testing Devices Market Analysis and Forecast, 2017–2027
5. Market Outlook
5.1. Technological Advancements
5.2. Roadside Drugs Testing Programs, by Country/Region
5.3. Regulatory Scenario Assessment
5.4. Key Industry Events (mergers, acquisitions, collaborations, launch & approvals, etc.)
6. Global Roadside Drug Testing Devices Market Analysis and Forecast, by Modality
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast, by Modality, 2017–2027
6.4. Market Attractiveness Analysis, by Modality
7. Global Roadside Drug Testing Devices Market Analysis and Forecast, by Substance
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast, by Substance, 2017–2027
22.214.171.124. Tetrahydrocannabinol (THC)
7.4. Market Attractiveness Analysis, by Substance
8. Global Roadside Drug Testing Devices Market Analysis and Forecast, by Sample Type
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Market Value Forecast, by Sample Type, 2017–2027
8.4. Market Attractiveness Analysis, by Substance
9. Global Roadside Drug Testing Devices Market Analysis and Forecast, by Region
9.1. Key Findings / Developments
9.2. Market Value Forecast, by Region, 2017–2027
9.2.1. North America
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Market Attractiveness Analysis, by Region
10. North America Roadside Drug Testing Devices Market Analysis and Forecast
Purchase Complete Report Now@ https://qyresearchmedical.com/report/checkout/111714/2900
You can place an order or ask any questions, please feel free to contact email@example.com | +1 9197 992 333
QYResearch Medical, focuses on custom research, management consulting, IPO consulting, industry chain research, and data base & seminar services. The company owns large basic databases (such as National Bureau of Statistics Database, Customs Import and Export Database, Industry Association Database, etc.), expert resources (including industry experts who own more than 10 years experiences on marketing or R&D in industries of healthcare services, medical technology & devices, etc.), professional survey team (the team members obtained more than 3 years market survey experience and more than 2 years deep expert interview experience), and excellent data analysis team (SPSS statistics and PPT graphics process team).
QYResearch Medical has more than 4000 global well-known customers, covering more than 30 industries including pharmaceuticals, medical technology & devices, healthcare services etc. Company services cover one-stop solution as Data-Analysis-Suggestion-Consulting Implementation. Research regions cover China, US, EU, Asia, Middle East and Africa, South America, Australia, and other regions in the world.
For Latest Update Follow Us: